Severe asthma consists of approximately 10% of asthmatics who have frequent and severe symptoms despite aggressive therapy with anti-inflammatory as well as other control medications. For this competitive renewal of our Severe Asthma Research Program (SARP), the clinical characterization of patients with severe asthma and assessment of inflammatory parameters will continue to be performed collaboratively so that data collected across the different centers can be evaluated and compared. We will determine corticosteroid responsiveness with the STAC characterization protocol to evaluate the importance of steroid resistance in severe asthma. We will contrast these more severe asthma subjects with milder asthmatics and obtain DNA samples for genetic analyses. We hypothesize that factors that cause severe asthma are caused by altered inflammatory responses that are related at least in part to polymorphisms in genes that regulate inflammation or affect airway structure. We also hypothesize that some patients develop severe asthma because of genetic differences that alter their responses to therapeutic agents. To test these hypotheses, we propose the following specific aims: (1) Collaborate with other SARP Investigators in the pharmacologic characterization of subjects to determine mechanisms responsible for corticosteroid responsiveness including high resolution CT scans and pharmacogenetics;(2) Continue to perform comprehensive characterizations of a larger set of subjects with severe and non severe asthma which will be used to discriminate severe from milder asthma;(3) Continue genetic association studies including analysis of related quantitative measures. This will include genes from our biologic studies (and those from other SARP centers) and genes in relevant pathways;(4) Perform a gene chip analysis of inflammatory genes on 200 of the most severe asthmatics and 200 of the most mild asthmatics (from all SARP sites) using the GeneChip ParAllele TrueTag 10K l&I Array run on our Affymetrix system (1,086 genes with >9000 SNPs). We feel strongly that collaborative research is necessary to meet the goals of this RFA and is crucial to genetic studies. We will continue to participate as an active member of SARP II.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL069167-10
Application #
7879983
Study Section
Special Emphasis Panel (ZHL1-CSR-L (M1))
Program Officer
Smith, Robert A
Project Start
2001-09-20
Project End
2012-06-30
Budget Start
2010-07-01
Budget End
2012-06-30
Support Year
10
Fiscal Year
2010
Total Cost
$621,305
Indirect Cost
Name
Wake Forest University Health Sciences
Department
Type
Schools of Medicine
DUNS #
937727907
City
Winston-Salem
State
NC
Country
United States
Zip Code
27157
Modena, Brian D; Bleecker, Eugene R; Busse, William W et al. (2017) Gene Expression Correlated with Severe Asthma Characteristics Reveals Heterogeneous Mechanisms of Severe Disease. Am J Respir Crit Care Med 195:1449-1463
Johnston, Henry Richard; Hu, Yi-Juan; Gao, Jingjing et al. (2017) Identifying tagging SNPs for African specific genetic variation from the African Diaspora Genome. Sci Rep 7:46398
Fitzpatrick, Anne M; Moore, Wendy C (2017) Severe Asthma Phenotypes - How Should They Guide Evaluation and Treatment? J Allergy Clin Immunol Pract 5:901-908
Kessler, Michael D; Yerges-Armstrong, Laura; Taub, Margaret A et al. (2016) Challenges and disparities in the application of personalized genomic medicine to populations with African ancestry. Nat Commun 7:12521
Mathias, Rasika Ann; Taub, Margaret A; Gignoux, Christopher R et al. (2016) A continuum of admixture in the Western Hemisphere revealed by the African Diaspora genome. Nat Commun 7:12522
Teodorescu, Mihaela; Broytman, Oleg; Curran-Everett, Douglas et al. (2015) Obstructive Sleep Apnea Risk, Asthma Burden, and Lower Airway Inflammation in Adults in the Severe Asthma Research Program (SARP) II. J Allergy Clin Immunol Pract 3:566-75.e1
Robinson, Mac B; Deshpande, Deepak A; Chou, Jeffery et al. (2015) IL-6 trans-signaling increases expression of airways disease genes in airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 309:L129-38
Marozkina, Nadzeya V; Wang, Xin-Qun; Stsiapura, Vitali et al. (2015) Phenotype of asthmatics with increased airway S-nitrosoglutathione reductase activity. Eur Respir J 45:87-97
Bunyavanich, Supinda; Schadt, Eric E; Himes, Blanca E et al. (2014) Integrated genome-wide association, coexpression network, and expression single nucleotide polymorphism analysis identifies novel pathway in allergic rhinitis. BMC Med Genomics 7:48
Voraphani, N; Gladwin, M T; Contreras, A U et al. (2014) An airway epithelial iNOS-DUOX2-thyroid peroxidase metabolome drives Th1/Th2 nitrative stress in human severe asthma. Mucosal Immunol 7:1175-85

Showing the most recent 10 out of 55 publications